Services for Hits-to-Leads discovery
Other expertise areas
|
The hits to leads phase in drug discovery aims to verify the validity of the found hits for further development. It typically contains stages like
- Re-testing of the hits in the same conditions as in the HTS program as well as confirmation by an alternative testing (orthogonal testing)
- Secondary screening by cellular assays
- Generation of IC50 and EC50 values
- Synthesis feasibility and cost analysis
- Patentability checking
- Assessment of the biophysical binding mode of the ligand to the target, using technologies NMR and surface plasmon resonance
- Development of the Structure-Activity-Relation models
As the confirmed hits are developed further, further properties are characterized, initially like
- Chemical stability
- Physicochemical properties
- Possible binding to plasma proteins
- Possible inhibition or induction of CYP P-450 enzymes
- Cell membrane permeability
- Possible cytotoxicity
- Kinetics of the metabolism
- Target selectivity
SBW Platform for Hits-to-Leads discovery
All our services are tailored per customers need. Our business models includes variations from fee for service / FTE to strategic business process outsourcing and partnership. Please see this page for our business models and here for an overview of our various solutions areas.
|